AMY ETHRIDGE: Open Payments
NPI 1578022109 · VINCENNES, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$950 in 46 payments from 22 companies in 2025. Trend: 2023 $257 · 2024 $915 · 2025 $950
Food & beverage: $850Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $210 |
| SEAGEN INC. | 1 | $100 |
| PFIZER INC. | 6 | $90 |
| AstraZeneca Pharmaceuticals LP | 4 | $71 |
| Janssen Biotech, Inc. | 3 | $58 |
| Merck Sharp & Dohme LLC | 3 | $54 |
| Gilead Sciences, Inc. | 2 | $51 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Genentech USA, Inc. | 2 | $35 |
| Geron Corporation | 1 | $34 |
Products named: KISQALI, PLUVICTO, KEYTRUDA, Trodelvy, TAGRISSO, RYBREVANT, ELREXFIO, Tecentriq.
Industry payments across IN — which companies pay providers there.
